Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The interferon receptors

S Pestka1

  • 1Department of Molecular Genetics and Microbiology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854-5635, USA.

Seminars in Oncology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patents and literature.

Applied biochemistry and biotechnology·2013
Same author

Up-regulation of a tumor-associated antigen (tag-72) by interferon-alpha and interferon-gamma in patients with cutaneous breast-cancer recurrences.

International journal of oncology·2011
Same author

Injection of irradiated b16 melanoma genetically-modified to secrete IFN-alpha causes regression of an established tumor.

International journal of oncology·2011
Same author

IFN-gamma and b7 as costimulators of antitumor immune-responses.

International journal of oncology·2011
Same author

Purification and cloning of interferon alpha.

Current topics in microbiology and immunology·2007
Same author

Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation.

Journal of immunology (Baltimore, Md. : 1950)·2001
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Interferon (IFN) receptors, crucial for immune responses, have been identified for both type I and type II IFNs. These receptors initiate complex signaling pathways involving kinases and transcription factors to regulate gene expression.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • The receptors for type I (alpha, beta, omega) and type II (gamma) interferons (IFNs) have been identified.
  • IFN-gamma receptor comprises IFN-gammaR1 (ligand binding) and IFN-gammaR2 (signal transduction).
  • Type I IFN receptor involves IFN-alphaR1 and IFN-alphaR2 chains with various isoforms.

Purpose of the Study:

  • To elucidate the molecular mechanisms of interferon receptor signaling.
  • To understand the roles of different receptor chains and associated kinases in signal transduction.
  • To explain the differential biological activities of type I IFNs based on receptor interactions.

Main Methods:

  • Identification and characterization of interferon receptor components.

Related Experiment Videos

  • Analysis of kinase activation (Jak1, Jak2, Tyk2) upon ligand binding.
  • Investigation of transcription factor recruitment and activation (Stat1, Stat2, p48).

    • Main Results:

    • IFN-gamma receptor signaling involves Jak1/Jak2 activation, Stat1alpha phosphorylation, and dimer formation.
    • Type I IFN receptor signaling involves Tyk2/Jak1 activation, Stat1/Stat2 recruitment, and formation of the ISGF-3 complex.
    • Different type I IFNs exhibit distinct receptor interaction patterns, correlating with their biological activities.

    Conclusions:

    • Both type I and type II interferon signaling pathways are initiated by specific receptor-ligand interactions.
    • Kinase activation and transcription factor complex formation are critical for mediating interferon's cellular effects.
    • The diversity of type I interferons is linked to their differential engagement with receptor components, influencing biological outcomes.